In the present project, we aim to contribute to the investigation of the potential use of botulinum toxin (BoNT-A) injections in the brain for the treatment of PD symptoms in the long-term. Particularly, we pretend provide evidence that allow optimize the use of BoNT-A, defining optimal concentrations and periodicity of treatment, as well as the description of the mechanisms involved.
The results obtained from this study are of great interest for MERZ, because this will permit continue with the evaluation of Botulinum toxin as a treatment for motor symptoms of PD, expanding the scope of application of this product that is already established in the in the industry, with delivery technologies available to humans.
Alejandra Veronica Parra Pena
Merz Pharma Canada Ltd
University of Western Ontario
Find the perfect opportunity to put your academic skills and knowledge into practice!Find Projects
The strong support from governments across Canada, international partners, universities, colleges, companies, and community organizations has enabled Mitacs to focus on the core idea that talent and partnerships power innovation — and innovation creates a better future.